Neurocognitive Dysfunction in Survivors of Childhood Brain Tumors

Seminars in Pediatric Neurology

Volumn 19, Issue 1, 2012, Pages 35-42

  Ullrich, Nicole J ^a,b   Embry, Leanne ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; DONEPEZIL; IMMUNOSUPPRESSIVE AGENT; METHYLPHENIDATE; MODAFINIL; STEROID;

ACADEMIC ACHIEVEMENT; BRAIN DISEASE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVOR; CHILDHOOD CANCER; CLINICAL ASSESSMENT; COGNITIVE DEFECT; COGNITIVE REHABILITATION; COMORBIDITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; EXECUTIVE FUNCTION; HUMAN; INTELLIGENCE QUOTIENT; MENTAL CONCENTRATION; NEUROPROTECTION; NEUROTOXICITY; OUTCOME ASSESSMENT; PRIMARY TUMOR; PSYCHOMOTOR PERFORMANCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEIZURE; SENSORY MEMORY; STEM CELL TRANSPLANTATION; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; COGNITION DISORDERS; HUMANS; NEUROSURGICAL PROCEDURES; RADIOTHERAPY; SURVIVORS;

EID: 84861524317     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2012.02.014     Document Type: Review

References (59)

1. Armstrong G.T., Liu Q., Yasui Y., et al. Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study. J Natl Cancer Inst 2009, 101:946-958.
2. Turner C.D., Chordas C.A., Liptak C.C., et al. Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only. Pediatr Blood Cancer 2009, 53:417-423.
3. Moore B.D. Neurocognitive outcomes in survivors of childhood cancer. J Pediatr Psychol 2005, 30:51-63.
4. Mulhern R.K., Palmer S.L. Neurocognitive late effects in pediatric cancer. Curr Probl Cancer 2003, 27:177-197.
5. Robinson K.E., Kuttesch J.F., Champion J.E., et al. A quantitative meta-analysis of neurocognitive sequelae in survivors of pediatric brain tumors. Pediatr Blood Cancer 2010, 55:525-531.
6. Mulhern R.K., Merchant T.E., Gajjar A., et al. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004, 5:399-408.
7. Packer R.J., Sutton L.N., Atkins T.E., et al. A prospective study of cognitive function in children receiving whole-brain radiotherapy and chemotherapy: Two-year results. J Neurosurg 1989, 70:707-713.
8. Ris M.D., Noll R.B. Long-term neurobehavioral outcome in pediatric brain-tumor patients: Review and methodological critique. J Clin Exp Neuropsychol 1994, 16:21-42.
9. Reimers T.S., Ehrenfels S., Mortensen E.L., et al. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol 2003, 40:26-34.
10. Butler R.W., Haser J.K. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev 2006, 12:184-191.
11. Askins M.A., Moore B.D. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol 2008, 23:1160-1171.
12. Ellenberg L., Liu Q., Gioia G., et al. Neurocognitive status in long-term survivors of childhood CNS malignancies: A report from the childhood cancer survivor study. Neuropsychology 2009, 23:705-717.
13. Nathan P.C., Patel S.K., Dilley K., et al. Guidelines for identification of, advocacy for, and intervention in neurocognitive problems in survivors of childhood cancer: A report from the Children's Oncology Group. Arch Pediatr Adolesc Med 2007, 161:798-806.
14. Hardy K.K., Bonner M.J., Willard V.W., et al. Hydrocephalus as a possible additional contributor to cognitive outcome in survivors of pediatric medulloblastoma. Psychooncology 2008, 17:1157-1161.
15. Packer R.J., Gurney J.G., Punyko J.A., et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: Childhood cancer survivor study. J Clin Oncol 2003, 21:3255-3261.
16. Khan R.B., Hunt D.L., Boop F.A., et al. Seizures in children with primary brain tumors: Incidence and long-term outcome. Epilepsy Res 2005, 64:85-91.
17. Ibrahim K., Appleton R. Seizures as the presenting symptom of brain tumours in children. Seizure 2004, 13:108-112.
18. Ye Z.C., Sontheimer H. Glioma cells release excitotoxic concentrations of glutamate. Cancer Res 1999, 59:4383-4391.
19. Bromley R.L., Leeman B.A., Baker G.A., et al. Cognitive and neurodevelopmental effects of antiepileptic drugs. Epilepsy Behav 2011, 22:9-16.
20. Sønderkaer S., Schmiegelow M., Carstensen H., et al. Long-term neurological outcome of childhood brain tumors treated by surgery only. J Clin Oncol 2003, 21:1347-1351.
21. Robertson P.L., Muraszko K.M., Holmes E.J., et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: A prospective study by the Children's Oncology Group. J Neurosurg 2006, 105:444-451.
22. Palmer S.L., Hassall T., Evankovich K., et al. Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma. Neuro Oncol 2010, 12:1311-1317.
23. Packer R.J., Meadows A.T., Rorke L.B., et al. Long-term sequelae of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 1987, 15:241-253.
24. Merchant T.E., Conklin H.M., Wu S., et al. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: Prospective evaluation of cognitive, endocrine, and hearing deficits. J Clin Oncol 2009, 27:3691-3697.
25. Ullrich N.J. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer. Dev Disabil Res Rev 2008, 14:229-237.
26. Ward C., Phipps K., de Sousa C., et al. Treatment factors associated with outcomes in children less than 3 years of age with CNS tumours. Childs Nerv Syst 2009, 25:663-668.
27. Carlson-Green B., Morris R.D., Krawiecki N. Family and illness predictors of outcome in pediatric brain tumors. J Pediatr Psychol 1995, 20:769-784.
28. Mitby P.A., Robison L.L., Whitton J.A., et al. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: A report from the childhood cancer survivor study. Cancer 2003, 97:1115-1126.
29. Meehan W.P., d'Hemecourt P., Collins C.L., et al. Computerized neurocognitive testing for the management of sport-related concussions. Pediatrics 2012, 129:38-44.
30. Vardy J., Wong K., Yi Q.L., et al. Assessing cognitive function in cancer patients. Support Care Cancer 2006, 14:1111-1118.
31. Snyder A.M., Maruff P., Pietrzak R.H., et al. Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychol 2008, 14:211-226.
32. Barr R.D., Simpson T., Whitton A., et al. Health-related quality of life in survivors of tumours of the central nervous system in childhood-A preference-based approach to measurement in a cross-sectional study. Eur J Cancer 1999, 35:248-255.
33. Zebrack B.J., Chesler M.A. Quality of life in childhood cancer survivors. Psychooncology 2002, 11:132-141.
34. Maddrey A.M., Bergeron J.A., Lombardo E.R., et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neuro Oncol 2005, 72:245-253.
35. Butler R.W., Copeland D.R. Attentional processes and their remediation in children treated for cancer: A literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002, 8:115-124.
36. Kuhnt D., Ganslandt O., Schlaffer S.M., et al. Quantification of glioma removal by intraoperative high-field magnetic resonance imaging: An update. Neurosurgery 2011, 69:852-862.
37. Ahn E.S., Goumnerova L. Endoscopic biopsy of brain tumors in children: Diagnostic success and utility in guiding treatment strategies. J Neurosurg Pediatr 2010, 5:255-262.
38. Pollack I.F., Keating R. New delivery approaches for pediatric brain tumors. J Neuro Oncol 2005, 75:315-326.
39. Kieran M.W., Turner C.D., Rubin J.B., et al. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol/Oncol 2005, 27:573-581.
40. Ellison D.W., Kocak M., Dalton J., et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol 2011, 29:1400-1407.
41. Cho Y.J., Tsherniak A., Tamayo P., et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol 2011, 29:1424-1430.
42. Packer R.J. Risk stratification of medulloblastoma: A paradigm for future childhood brain tumor management strategies. Curr Neurol Neurosci Rep 2011, 11:124-126.
43. Kirsch D.G., Tarbell N.J. Conformal radiation therapy for childhood CNS tumors. Oncologist 2004, 9:442-450.
44. Kirsch D.G., Tarbell N.J. New technologies in radiation therapy for pediatric brain tumors: The rationale for proton radiation therapy. Pediatr Blood Cancer 2004, 42:461-464.
45. Merchant T.E., Hua C.H., Shukla H., et al. Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 2008, 51:110-117.
46. Mulrooney D.A., Ness K.K., Neglia J.P., et al. Fatigue and sleep disturbance in adult survivors of childhood cancer: A report from the childhood cancer survivor study (CCSS). Sleep 2008, 31:271-281.
47. Rosen G., Brand S.R. Sleep in children with cancer: Case review of 70 children evaluated in a comprehensive pediatric sleep center. Support Care Cancer 2011, 19:985-994.
48. Butler R.W., Copeland D.R., Fairclough D.L., et al. A multi-center, randomized clinical trial of cognitive rehabilitation program for childhood survivors of pediatric malignancy. J Consult Clin Psychol 2008, 76:367-378.
49. Patel S.K., Katz E.R., Richardson R., et al. Cognitive and problem solving training in children with cancer: A pilot project. J Pediatr Hematol/Oncol 2009, 31:670-677.
50. Klingberg T., Fernell E., Olesen P.J., et al. Computerized training of working memory in children with ADHD-A randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 2005, 44:177-186.
51. Hardy K.K., Willard V.W., Bonner M.J. Computerized cognitive training in survivors of childhood cancer: A pilot study. J Pediatr Oncol Nurs 2011, 28:27-33.
52. Schatz J., Kramer J.H., Ablin A., et al. Processing speed, working memory, and IQ: A developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 2000, 14:189-200.
53. Reddick W.E., White H.A., Glass J.O., et al. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 2003, 97:2512-2519.
54. Conklin H.M., Reddick W.E., Ashford J., et al. Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol 2010, 28:4465-4472.
55. Shaw E.G., Rosdhal R., D'Agostino R.B., et al. Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. J Clin Oncol 2006, 24:1415-1420.
56. Castellino SM, Tooze JA, Flowers L, et al: Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: A pilot study. Pediatr Blood Cancer (in press).
57. Kohli S., Fisher S.G., Tra Y., et al. The effect of modafinil on cognitive function in breast cancer survivors. Cancer 2009, 115:2605-2616.
58. Gehring K, Patwardhan SY, Collins R, et al: A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neuro Oncol (in press).
59. Blackhall L., Petroni G., Shu J., et al. A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med 2009, 12:433-439.